CLINICAL ROLE -
The Pharmacist’s Role in Maximizing HIV Antiretroviral Therapy
Through ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.
Read More
Takhzyro for Hereditary Angioedema
On August 23, 2018, the FDA approved lanadelumab-flyo (Takhzyro; Shire) for the prophylaxis treatment and prevention of hereditary angioedema (HAE) in patients 12 years or older.
FDA Biosimilar Plan Offers Employers Saving Strategy Solution
Based on 2017 FDA research, the delayed market launch of nine biosimilars represented $4.5 billion in potential savings.
